High Field MRI For Optimized Translational 1H Multiparametric and Multinuclear Imaging Research
High Field MRI For Optimized Translational 1H Multiparametric and Multinuclear Imaging Research
批准号:
10175910
负责人:
John Kurhanewicz
金额:
$200.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-04-15 至 2024-04-14
关键词:
2,4-DinitrophenolAddressAgingAwardBasic ScienceBiomedical ResearchBrain DiseasesClinicalClinical ResearchCommunicable DiseasesCommunitiesDeuteriumDiabetes MellitusEducational workshopEquipmentExtramural ActivitiesFundingGoalsGrantHeart DiseasesHuman ResourcesImageIndividualInformation DisseminationInfrastructureInternationalInternetLiver diseasesMagnetic Resonance ImagingMusOncologyPharmacy facilityPhosphorusPrincipal InvestigatorRattusResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesRodentSiteStudentsTechniquesTechnologyTrainingUnited States National Institutes of HealthVisitbioimagingcostdrug discoveryexperiencefaculty supportimaging capabilitiesimaging studyinstrumentinstrumentationinvestigator trainingmedical schoolspre-clinicalpreclinical imagingprogramsradiological imagingspectroscopic imagingstudent trainingsymposiumweb site
中文摘要
项目总结/文摘
英文摘要
Project Summary/Abstract
The proposed replacement of a unique but aging, commercially unsupported, mouse only vertical bore Varian
14T pre-clinical MRI to a state-of-the-art Bruker 9.4T horizontal bore MRI scanner large enough for mice and
rats is justified by the research needs of 23 currently funded projects (21 NIH grants) in translational and clinical
biomedical research at UCSF and internationally through the NIH P41 supported Hyperpolarized MRI
Technology Resource Center. This S10 HEI award is critical to enable the replacement of aging pre-clincial MRI
to state-of-the-art, by addressing current limitations facing funded and new research projects. This application is
supported by strong institutional support covering ≈ 1/3 of the cost and siting of the 9.4T MRI scanner, and a
Justification of Need which not only includes strong research support but also substantial training, a well-
established administrative infrastructure through the UCSF Research Resource Program’s (RRP) Pre-clinical
Imaging Core, and the UCSF Hyperpolarized MRI Technology Resource Center (HMTRC). The RRP core and
HMTRC provide the highly experienced technical support, training, expert personnel, ancillary equipment and
infrastructure for dissemination of results/techniques to make this major high-end instrumentation project
optimally successful in its goal to provide state-of-the-art instrumentation to both intra- and extramural users.
The UCSF RRP Pre-Clinical Imaging Core, where the 9.4T MRI will be sited, provides advanced pre-clinical
imaging instrumentation consisting of 4 scanners, 2 DNP polarizers, other supporting small equipment, wet lab
facilities, as well as expert personnel for translational pre-clinical imaging research for the entire UCSF campus.
Specifically, the Pre-clinical Imaging Core serves a broad research and clinical community (50+ Principal
Investigators in the Schools of Medicine and Pharmacy) and supports a broad spectrum of basic and clinical
research (oncology, diabetes, cardiac disease, brain disorders, liver disease, infectious diseases and drug
discovery). The equipment will be used for training a large number of students at UCSF either as part of formal
graduate courses or research projects. Furthermore, this instrument will also be used to train investigators from
around the world through the UCSF Hyperpolarized MRI Technology Resource Center as well as junior faculty
supported by the Department of Radiology and Biomedical Imaging. The new pre-clinical MRI will provide
critically-needed, expanded pre-clinical MR imaging capabilities by providing the ability to do larger rodent
studies, and by using hardware enhancements to go in exciting new directions such as deuterium and
phosphorus spectroscopic imaging studies.
In summary, this equipment replacement S10 proposal is critical to remove a major bottleneck limiting pre-clinical
MRI research and will also benefit the training of students at UCSF and external investigators nationally and
internationally through hands-on workshops, individual visits, web-conferences, website dissemination, and
collaborative multi-site research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical imaging characterization and resource development of PDX SCNC prostate cancer murine models
-
批准号:10378320
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:John Kurhanewicz
-
依托单位:
Co-Clinical Quantitative Imaging of Small Cell Neuroendocrine Prostate Cancer Using Hyperpolarized 13C MRI
-
批准号:10669081
-
项目类别:
-
资助金额:$65.68万
-
财政年份:2020
-
负责人:John Kurhanewicz
-
依托单位:
Co-Clinical Quantitative Imaging of Small Cell Neuroendocrine Prostate Cancer Using Hyperpolarized 13C MRI
-
批准号:10057724
-
项目类别:
-
资助金额:$67.02万
-
财政年份:2020
-
负责人:John Kurhanewicz
-
依托单位:
Characterization of PDX SCNC prostate cancer metastatic murine models and development of associated research resources
-
批准号:10533469
-
项目类别:
-
资助金额:$7.59万
-
财政年份:2020
-
负责人:John Kurhanewicz
-
依托单位:
Co-Clinical Quantitative Imaging of Small Cell Neuroendocrine Prostate Cancer Using Hyperpolarized 13C MRI
-
批准号:10470345
-
项目类别:
-
资助金额:$65.68万
-
财政年份:2020
-
负责人:John Kurhanewicz
-
依托单位:
Co-Clinical Quantitative Imaging of Small Cell Neuroendocrine Prostate Cancer Using Hyperpolarized 13C MRI
-
批准号:10256057
-
项目类别:
-
资助金额:$67.02万
-
财政年份:2020
-
负责人:John Kurhanewicz
-
依托单位:
Co-Clinical Quantitative Imaging of Small Cell Neuroendocrine Prostate Cancer Using Hyperpolarized 13C MRI
-
批准号:10737795
-
项目类别:
-
资助金额:$7.44万
-
财政年份:2020
-
负责人:John Kurhanewicz
-
依托单位:
Metabolic imaging comparisons of patient-derived models of renal cell carcinoma
-
批准号:9753176
-
项目类别:
-
资助金额:$62.63万
-
财政年份:2017
-
负责人:John Kurhanewicz
-
依托单位:
Metabolic imaging comparisons of patient-derived models of renal cell carcinoma
-
批准号:10227078
-
项目类别:
-
资助金额:$63.36万
-
财政年份:2017
-
负责人:John Kurhanewicz
-
依托单位:
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING
-
批准号:10116302
-
项目类别:
-
资助金额:$60.09万
-
财政年份:2017
-
负责人:John Kurhanewicz
-
依托单位:
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods
-
批准号:8573124
-
项目类别:
-
资助金额:$119.1万
-
财政年份:2013
-
负责人:John Kurhanewicz
-
依托单位:
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods
-
批准号:9107862
-
项目类别:
-
资助金额:$118.54万
-
财政年份:2013
-
负责人:John Kurhanewicz
-
依托单位:
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI
-
批准号:9058042
-
项目类别:
-
资助金额:$71.29万
-
财政年份:2013
-
负责人:John Kurhanewicz
-
依托单位:
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods
-
批准号:8891426
-
项目类别:
-
资助金额:$116.26万
-
财政年份:2013
-
负责人:John Kurhanewicz
-
依托单位:
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods
-
批准号:8713993
-
项目类别:
-
资助金额:$114.78万
-
财政年份:2013
-
负责人:John Kurhanewicz
-
依托单位:
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI
-
批准号:8585007
-
项目类别:
-
资助金额:$70.44万
-
财政年份:2013
-
负责人:John Kurhanewicz
-
依托单位:
PET and MR-Compatible Bioreactor for Cross-Platform Biomarker Development
-
批准号:8520274
-
项目类别:
-
资助金额:$15.32万
-
财政年份:2012
-
负责人:John Kurhanewicz
-
依托单位:
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy
-
批准号:8551645
-
项目类别:
-
资助金额:$56.37万
-
财政年份:2012
-
负责人:John Kurhanewicz
-
依托单位:
PET and MR-Compatible Bioreactor for Cross-Platform Biomarker Development
-
批准号:8401876
-
项目类别:
-
资助金额:$13.55万
-
财政年份:2012
-
负责人:John Kurhanewicz
-
依托单位:
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy
-
批准号:8698716
-
项目类别:
-
资助金额:$58.33万
-
财政年份:2012
-
负责人:John Kurhanewicz
-
依托单位:
海外基金